SEATTLE -- Even for new kidney transplant recipients with diabetes, GLP-1 receptor agonists (RAs) were safe and effective, a researcher reported here. In a retrospective study, kidney transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results